|
|
Expression and clinical significance of cyclooxygenase-2 in Hashimoto′s thyroiditis complicated with papillary thyroid carcinoma |
DU Jia-wei |
Department of General Surgery,Bengang General Hospital of Liaoning Provincial Health Industry Group,Liaoning Province,Benxi 117000,China |
|
|
Abstract Objective To explore the expression and clinical significance of cyclooxygenase-2(COX-2)in Hashimoto′s thyroiditis(HT)combined with papillary thyroid carcinoma(PTC),in order to provide guidance for clinical diagnosis and treatment.Methods The paraffin specimens of 85 patients with HT and PTC in the Department of Pathology of Bengang General Hospital of Liaoning Health Industry Group from July 2019 to July 2020 were collected to detected the expression of COX-2.The positive expression rates of COX-2 in cancer tissues and adjacent tissues were compared,the clinical data of the patients were analyzed,the positive expression rate of COX-2 in cancer tissues of patients with different pathological characteristics [tumor number,tumor diameter,TNM stage,capsule invasion,lymph node metastasis(LNM)]were compared.Results The positive expression rate of COX-2 in cancer tissues of patients with HT combined with PTC was higher than that in adjacent tissues,the difference was significant statistically(P<0.05).The positive expression rate of COX-2 in HT and PTC patients with capsule invasion was higher than that in patients without capsule invasion,the positive expression rate of COX-2 in HT patients with PTC and LNM was higher than that in patients without LNM,the differences were statistically significant(P<0.05).There was no significant difference between the positive expression rate of COX-2 in cancer tissues of different tumor number,tumor diameter,TNM stage(P >0.05).Logistic regression analysis showed that the positive expression of COX-2 might be the influencing factor of capsule invasion and LNM in HT patients with PTC(OR>1,P<0.05).Conclusion The abnormally high expression of COX-2 is closely related to the disease development of HT combined with PTC,which may indicate the occurrence of LNM and capsule invasion.The severity of HT combined with PTC can be predicted based on the expression of COX-2.
|
|
|
|
|
[4] |
蒋世烨,孙为豪.幽门螺杆菌感染和环氧化酶-2 在胃癌发生中的作用研究进展[J].东南国防医药,2019,21(4):392-396.
|
[5] |
桂永燕,高社干.环氧化酶-2 基因在食管上皮癌变中的表达及其临床意义的研究进展[J].实用癌症杂志,2020,35(4):693-694.
|
[6] |
周焰实.桥本甲状腺炎合并乳头状甲状腺癌的研究进展[J].中国肿瘤临床与康复,2017,24(12):1534-1536.
|
[7] |
邬一军,朱敏洁,田赫迪.桥本甲状腺炎合并甲状腺乳头状癌的诊疗进展[J].浙江医学,2019,41(15):1571-1574.
|
[8] |
郭广洋,王宏,闫寒冰.结直肠癌COX-2、MSS 表达与临床病理特征的相关性分析[J].实用癌症杂志,2020,35(3):391-394.
|
[9] |
李中勇,李乐.桥本甲状腺炎合并甲状腺乳头状癌中环氧化酶-2、Survivin 和胸腺基质淋巴细胞的表达及临床意义[J].中国耳鼻咽喉头颈外科,2019,26(6):298-301.
|
[10] |
张杰东,朱传东,刘杜先,等.甲状腺乳头状癌B-raf 基因突变及Caveolin-1 和COX-2 蛋白表达的临床意义[J].临床与病理杂志,2018,38(7):1434-1439.
|
[11] |
朱跃坤,赵宪琪,汪大伟,等.环氧化酶-2 反义RNA 联合塞莱昔布对肝癌细胞增殖和凋亡的影响[J].临床肝胆病杂志,2018,34(12):2614-2618.
|
[2] |
董云伟,陈革,陈曙光,等.合并慢性淋巴细胞性甲状腺炎的甲状腺乳头状癌的临床病理特点及淋巴结转移风险分析[J].中华普通外科杂志,2019,34(3):225-229.
|
[3] |
姜晓倩,赵岭岭,李景光,等.结肠癌中骨桥蛋白与环氧化酶-2的表达及临床意义[J].现代消化及介入诊疗,2019,24(2):52-55.
|
[12] |
贾宗良,朱宏升,柴明明,等.甲状腺乳头状癌中MMP2、COX-2、VEGF 和MVD 的表达及临床意义[J].西安交通大学学报(医学版),2015,36(3):362-367,382.
|
[13] |
陈艺萍,潘建基.环氧化物酶-2 在肿瘤微环境中的作用研究进展[J].肿瘤学杂志,2019,25(11):990-994.
|
[14] |
刘卫梅,王玉,王泽英.COX-2,MMP-14 在甲状腺癌中的表达及其临床意义[J].实用癌症杂志,2018,33(6):881-882.
|
[1] |
王欣,郑凯,黄敏.合并桥本甲状腺炎的甲状腺乳头状癌临床病理及超声特征[J].中国医学影像学杂志,2018,26(10):33-37.
|
[15] |
杨勇,赵子龙,周国江.PTEN,COX2 蛋白在复发转移性大肠癌患者组织中的表达及临床意义[J].医学临床研究,2018,35(12):2311-2314.
|
[16] |
魏慧,张卿.选择性COX-2 抑制剂联合顺铂对肺癌新生血管的影响及机制研究[J].国际呼吸杂志,2020,40(7):487-492.
|
[17] |
蔡海瑜,刘爱珍,宋芷霜,等.雌激素通过上调COX-2 的表达影响宫颈癌Hela 细胞的增殖及化疗敏感性[J].实用医学杂志,2020,36(11):1442-1446.
|
|
|
|